Cargando…
A Comparison between 10-day and 12-day Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial
BACKGROUND Helicobacter pylori (H. pylori) infection is one of the most common bacterial infections worldwide, which is associated with peptic ulcer disease and gastric cancer. In this study, we compared the efficacy of 10-day versus 12-day concomitant therapy as the first-line treatment for H. pylo...
Autores principales: | Bari, Zohreh, Fakheri, Hafez, Taghvaei, Tarang, Yaghoobi, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320987/ https://www.ncbi.nlm.nih.gov/pubmed/32626563 http://dx.doi.org/10.34172/mejdd.2020.169 |
Ejemplares similares
-
Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter
pylori eradication
por: Kazemi Veysari, Arash, et al.
Publicado: (2023) -
A Comparison between Hybrid and Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial
por: Alhooei, Saman, et al.
Publicado: (2016) -
Efficacy of 14-day concomitant quadruple therapy and 14-day high-dose dual therapy on H. pylori eradication
por: Yadollahi, Behsood, et al.
Publicado: (2022) -
Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori
por: Mokhtare, Marjan, et al.
Publicado: (2015) -
Eradication of Helicobacter Pylori in Iran: A Review
por: Fakheri, Hafez, et al.
Publicado: (2018)